Breast Cancer Risk Continues Despite Negative Gene Mutation Tests

A recent study reveals that women with a family history of breast cancer might still face significant risks, even if they test negative for BRCA1 and BRCA2 gene mutations. This highlights that their risk remains higher than the general population.

Understanding BRCA1 and BRCA2 Testing

BRCA1 and BRCA2 gene testing is advised for women with personal or family histories of certain cancers. Research indicates that up to 10% of breast cancer cases are hereditary, resulting from inherited gene changes, according to the American Cancer Society. Women carrying BRCA1 or BRCA2 mutations have greater chances of an early diagnosis, cancer in both breasts, and increased risks for other cancers such as ovarian cancer.

Implications of a Negative Test

“The risk of cancer in these women is elevated compared to the general population.” — Fahima Dossa

A study by Cedars-Sinai Health Sciences University reveals that even with negative test results, these women are at a heightened risk of breast cancer over their lifetime. Fahima Dossa, a surgical oncologist, emphasizes that many women undergoing these tests have strong family cancer histories. Although a negative result may seem reassuring, the risk remains for those with significant family histories.

Analysis of BRCA Testing Data

The study analyzed records of nearly 16,000 women who underwent BRCA testing in Ontario, Canada, from 2007 to 2016. Findings indicate a 25% lifetime risk of developing breast cancer for women testing negative for BRCA mutations. Those with a variant of unknown significance have a 30% risk, compared to the average population’s 13% chance.

Family History as a Critical Factor

The study shows that family history significantly impacts breast cancer risk. Women testing positive for BRCA mutations face a 56% to 86% likelihood of developing cancer, depending on the number of affected family members.

Preventive Strategies and Future Research

Dossa indicates data as a key starting point for discussions about risk-reducing strategies like high-risk screening, chemoprevention, and surgery, tailored to individual histories.

Ongoing research is exploring cancer risk timelines and preventive surgery needs. Additionally, investigations into correlations between BRCA genes and cardiovascular health are underway, considering chemotherapy’s potential impact.

Public Recommendations

Kotryna Temcinaite from Breast Cancer Now urges identifying women at greater risk to enable earlier detection and prevention. Despite most breast cancers not being hereditary, women are encouraged to regularly self-examine, consult doctors for any changes, and attend screenings. Small lifestyle adjustments such as reducing alcohol intake, maintaining a healthy weight, and staying physically active can help lower breast cancer risk.